The Food and Drug Administration has rescheduled its radiological devices advisory panel meeting to review Computerized Thermal Imaging’s breast imaging system. According to the Lake Oswego, OR-based developer, the panel meeting will be held December 10 in Gaithersburg, MD. The panel will discuss and make recommendations regarding the manufacturer’s premarket approval application for the product.
AuntMinnie.com staff writersOctober 16, 2002
Related Reading
CTI BCS 2100 slated for FDA panel review, July 25, 2002
CTI faces shareholder lawsuits, May 15, 2002
CTI to receive $22.5 million in financing, December 21, 2001
CTI begins in-house manufacturing, August 15, 2001
CTI signs on four distributors, August 9, 2001
Copyright © 2002 AuntMinnie.com